Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process-Reference-Cited by-同舟云学术

Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process

Published:2011-05-13 Issue:11 Volume:51 Page:2367-2376
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:

Author:

Cancelas Jose A.,Dumont Larry J.,Rugg Neeta,Szczepiorkowski Zbigniew M.,Herschel Louis,Siegel Alan,Pratt P. Gayle,Worsham D. Nicole,Erickson Anne,Propst Meisa,North Anne,Sherman Claire D.,Mufti Nina A.,Reed William F.,Corash Laurence

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2011.03163.x/fullpdf

Reference41 articles.

1. Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with men;Anderson;Transfusion,2009

2. Retrovirus epidemiology donor study. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?;Wang;Transfusion,2005

3. NHLBI Retrovirus Epidemiology Study (REDS). The 2003 West Nile virus United States epidemic: the America's blood centers experience;Kleinman;Transfusion,2005

4. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors;Busch;Transfusion,2005

5. Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period;Cazenave;Transfusion,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogen reduced red blood cells as an alternative to irradiated and washed components with potential for up to 42 days storage;BLOOD TRANSFUS-ITALY;2024

2. Measurement of post‐transfusion red blood cell survival kinetics in sickle cell disease and β‐Thalassemia: A biotin label approach;Transfusion;2022-08-02

3. PATHOGEN REDUCTION OF BLOOD COMPONENTS;Military Medical Science Letters;2022-03-04

4. Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells;Transfusion;2020-07-21

5. Progress towards an appropriate pathogen reduction technology for whole blood in Africa;ISBT Science Series;2019-11-14